4//SEC Filing
TAUSCHER MARK R 4
Accession 0001556244-19-000109
CIK 0001011060other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 6:10 PM ET
Size
6.5 KB
Accession
0001556244-19-000109
Insider Transaction Report
Form 4
TAUSCHER MARK R
Director
Transactions
- Exercise of In-Money
Common Stock
2019-12-05$0.06/sh+50,000$3,000→ 50,000 total - Exercise of In-Money
Common Stock
2019-12-05+350,000→ 400,000 total
Footnotes (2)
- [F1]Shares acquired through exercise of options granted pursuant to the 2003 Stock Option Plan at an exercise price of $0.06 per share i consideration of cash.
- [F2]Shares acquired from the exercise of options pursuant to the 2017 Non-Qualified Equity Incentive Plan (the "2017 Plan") which provided for the exercise of options into 500,000 shares of the Company's common stock at an exercise price of $0.06 per share which were exercised on a cashless basis, as provided for in the 2017 Plan, resulting in the issuance of 350,000 shares, net.
Documents
Issuer
AdvanSource Biomaterials Corp
CIK 0001011060
Entity typeother
Related Parties
1- filerCIK 0001196671
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 6:10 PM ET
- Size
- 6.5 KB